Asymmetric Learning is a (probably) weekly blog about learning better than your competitor… Innovations in Pharmaceutical Innovation

From Mike Rea, CEO of IDEA Pharma, this blog aims to explore pharmaceutical innovation in general, and more specifically the approach to using the learning process for competitive advantage: where the drug might work, what might be approvable, and what commercial value it might have.

‘Learning’ has dimensions that matter, and so does ‘better’. When the ability to learn is a superpower (and where is it not?), this blog examines how to get there.

Why subscribe?

Subscribe to get full access to the newsletter and website. Never miss an update.

Stay up-to-date

You won’t have to worry about missing anything. Every new edition of the newsletter goes directly to your inbox.

Join the crew

Be part of a community of people who share your interests.

To find out more about the company that provides the tech for this newsletter, visit Substack.com.

User's avatar

Subscribe to Asymmetric Learning - Pharmaceutical Innovation

Innovations in Pharmaceutical Innovation A blog/ part-work from Mike Rea, CEO of IDEA Pharma, exploring pharmaceutical innovation in general, and more specifically the approach to using the learning process for competitive advantage

People

Head of Strategy and Thought Leadership, SAI Group; was CEO, IDEA Pharma. Pharmaceutical innovation geek. Senior Fellow @fastercures. Author: Pharmaceutical Positioning. My record label: Medical Records. Large, Geordie, dog fan, street-foodie